Sept 20 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical firm backed by healthcare giant Kaiser Permanente, filed for an initial public offering in the United States on Friday. The filing comes ...
Some results have been hidden because they may be inaccessible to you